Dose Finding Study of MCI-186 in Acute Ischemic Stroke

Summary

To investigate the efficacy and safety of MCI-186 (bolus followed by continuous infusion) in acute ischemic stroke patients through a double-blind, parallel-group comparison with the existing MCI-186 dosing regimen (administration twice daily for 14 days) as the control.

Timeline

Start

2017-11-17

Primary completion

2018-05-14

Completion

2018-05-14

Drugs

Indications